Earnings History Data for Cidara Therapeutics, Inc. (CDTX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Cidara Therapeutics, Inc.

Cidara Therapeutics, Inc. is a biotechnology company. The company is focused on the discovery, development and commercialization of novel anti-infectives. Its product pipeline includes CD101 IV, a long-acting echinocandin antifungal, CD101 topical and C001 which are in different clinical trial. The company developed its product using Cloudbreak(TM) immunotherapy platform. Cidara Therapeutics, Inc. is headquartered in San Diego, California.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
13-05-2021 AH 4:45 PM ET
(May 13)
CDTX Cidara Therapeutics, Inc. 97.06 -0.39 -0.17 -0.46 Cidara Therapeutics EPS misses by $0.05, misses on revenue
[5/13/2021 5:17 PM]
2.00 -0.02 
(-0.99%)
2.01 -0.01 
(-0.50%)
1.76 - 4.45 266,999 480,000 9,286
05-11-2020 AH 4:50 PM ET
(Nov 5)
CDTX Cidara Therapeutics, Inc. 104.82 -0.41 -0.48 0.08 Cidara Therapeutics EPS misses by $0.01, misses on revenue
[11/5/2020 5:35 PM]
2.34 -0.20 
(-7.87%)
2.50 0.02 
(0.81%)
1.30 - 4.45 287,372 212,399 230
13-08-2020 AH CDTX Cidara Therapeutics, Inc. 165.70 -0.45 -0.23 -0.49 Cidara Therapeutics EPS misses by $0.14, misses on revenue
[8/13/2020 4:59 PM]
3.78 0.0 
(0.00%)
0.0 0.0 
(0.00%)
1.22 - 4.45 104,321 203,500 0
13-05-2020 AH After the close
(May 13)
CDTX Cidara Therapeutics, Inc. 132.39 -0.46 -0.34 -0.60 Cidara Therapeutics EPS misses by $0.12, beats on revenue
[5/13/2020 4:58 PM]
2.99 0.07 
(2.40%)
2.95 0.03 
(1.03%)
1.22 - 4.44 146,384 293,949 320